recombinant human tyrosine phosphatase protein

Recombinant human tyrosine phosphatase protein is an investigational biotherapeutic being developed by Elea Laboratories (Laboratorio Elea Phoenix). Currently in the research phase, this recombinant protein program focuses on the therapeutic application of tyrosine phosphatases, which are essential enzymes that regulate signal transduction by dephosphorylating tyrosine residues on target proteins. By modulating these signaling pathways, the drug is intended to address conditions characterized by dysregulated cellular signaling, such as autoimmune diseases, inflammatory disorders, or certain malignancies. As a recombinant protein, it is designed to mimic or supplement endogenous phosphatase activity to restore homeostatic signaling within the cell.

Other names

recombinant human PTPProteína recombinante humana tirosina fosfatasa